期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Research in Chinese Medicine. 2022; 2: (3) ; 62-65 ; DOI: 10.12208/j.ircm.20220063.

Research Status of Prescription Granules of tonifying traditional Chinese medicine
补虚类中药配方颗粒的研究进展

作者: 黄新宇, 季巧遇 *

江西中医药大学药学院 江西南昌

江西中医药大学药学院 江西南昌;江中药业股份有限公司 江西南昌

*通讯作者: 季巧遇,单位:江西中医药大学药学院 江西南昌;江中药业股份有限公司 江西南昌;

发布时间: 2022-10-19 总浏览量: 278

摘要

目的 了解补虚类中药配方颗粒在国内各医院中的适用现状,并分析补虚类中药配方颗粒现存的问题及解决方案。方法 检索知网2015年1月—2022年7月发表的各医院补虚类中药配方颗粒的相关文献,相关文章中的作者信息和发表年限以及补虚类中药配方颗粒在医院中的使用情况、在总体的配方颗粒销售量中的占比情况、中药配方颗粒的使用排名、存在的问题等信息,归纳总结出近6年发表的补虚类中药配方颗粒相关文献的现状,探讨目前补虚类中药配方颗粒发展中出现的问题。结果 总计检索得到文献23篇,实际应用21篇分析结果表明:6年内关于补虚类中药配方颗粒的临床使用情况的相关文献报道较少,但现有文献中记载的内容可看出除特殊类医院外绝大多数医院补虚类为中药配方颗粒销量的第一名,为医院采购提出了一定的参考价值。结论 中药配方颗粒存在问题(不同产地存在质量差异、有效成分含量),应加大相应研究,提高质量。

关键词: 补虚类;中药配方颗粒;质量差异;有效成分含量

Abstract

Objective To understand the application status of tonifying traditional Chinese medicine granules in various hospitals in China, and to analyze the existing problems and solutions of tonifying traditional Chinese medicine granules.
Methods Relevant literatures of Chinese medicine formula granules for supplementing deficiency in various hospitals published by CNKI from January 2015 to July 2022 were retrieved, the author information and publication years in relevant articles, as well as the use of Chinese medicine formula granules for supplementing deficiency in hospitals, The proportion of the total sales volume of formula granules, the ranking of the use of traditional Chinese medicine formula granules, existing problems and other information, summarizes the current situation of the literature related to tonic Chinese medicine formula granules published in the past 6 years, and discusses the current tonic formula granules. Problems in the development of traditional Chinese medicine formula granules.
Results A total of 23 literatures were retrieved, and 20 were actually applied. The analysis results showed that there were few relevant literature reports on the clinical use of tonifying traditional Chinese medicine granules within 6 years. The vast majority of hospitals outside the hospital are the first in the sales of traditional Chinese medicine formula granules, which provides a certain reference value for hospital procurement.
Conclusion   There are problems in traditional Chinese medicine formula granules (quality differences and active ingredient content in different origins), and corresponding research should be increased to improve the quality.

Key words: tonic; traditional Chinese medicine formula granules; quality difference; active ingredient content

参考文献 References

[1] 汪友东.使用 Meta 分析中药配方颗粒与传统中药饮片的临床疗效差异 [J]. 首都食品与医药,2020,27(12):197-198.

[2] 吴玉秀,张永芳,林羽慧,余小雁,李少婷,钟邱.2013~2017年我院补虚类中药饮片使用情况分析[J].海峡药学,2019,31(08):248-250. 

[3] 李雪英,余文惠,赖荣芬.我院中药免煎颗粒使用分析[J].临床合理用药杂志,2018,11(25):105-106+108.

[4] 郭振武.中医扶正补益药的临床应用〔J〕.秦山医学院学报,2008,29( 6) : 475.

[5] 李曦,张丽宏,王晓晓,等.当归化学成分及药理作用研究进展[J].中药材,2013,36(6):1023-1028. 

[6] 邓雪琪,管小军,黄娜娜,等.HPLC 法同时测定当归中8 种成分[J].中成药,2020,42(8):2075-2079.

[7] 李伟霞,泥文娟,王晓艳,刘现磊,李琨,张书琦,陈小菲,唐进法.当归化学成分、药理作用及其质量标志物(Q-marker)的预测分析[J/OL].中华中医药学刊:1-19[2021-12-28].

[8] 戴瑜婷,张雪燕,王艺璇,范永升,杨丹,刘永琦,修明慧,和建政.黄芪的现代研究进展及其质量标志物的预测分析[J/OL].中国中药杂志:1-13[2021-12-28].

[9] 胡妮娜,张晓娟.黄芪的化学成分及药理作用研究进展[J].中医药信息,2021,38(01):76-82.

[10] BAILLY C.Atractylenolides,essential components of Atractylodes-based traditional herbal medicines: antioxidant,anti-inflammatory and anticancer properties[J]. Eur J Pharmacol,2020,891: 173735. 

[11] ZHU B,ZHANG Q L,HUA J W, et al.The traditional uses,phytochemistry,and pharmacology of Atractylodesmacroceph-ala Koidz.a review[J].J Ethnopharmacol,2018,226: 143 - 167.

[12] 左军,张金龙,胡晓阳.白术化学成分及现代药理作用研究进展[J].辽宁中医药大学学报,2021,23(10):6-9.

[13] 徐佳新,许浚,曹勇,朱月健,李翔宇,葛德助,马磊,张铁军,刘昌孝.中药白芍现代研究进展及其质量标志物的预测分析[J].中国中药杂志,2021,46(21):5486-5495.

[14] 申文玲,彭相君,于丽萍.熟地黄活性成分药理作用的相关研究[J].临床医药文献电子杂志,2019,6(85):194.

[15] 周婷.中药配方颗粒与传统中药饮片治疗阴虚火旺型盗汗的效果观察[J].基层医学论坛,2021,25(31):4568-4569.

[16] 张红梅,宋景政,谭红胜,徐宏喜,李松林,陈士林.从汤剂到颗粒剂:中药配方颗粒20年回顾与展望[J].世界科学技术(中医药现代化),2012,14(04):1740-1753. 

[17] 王成强.中药配方颗粒和中药饮片的主要特点及效果对比研究[J].中外女性健康研究,2019(12):125+142. 

[18] 曾瑾,陈平,尹竹君,李莉,戴瑛,鄢良春,赵军宁,杨安东,周厚成,周翔,周维.中药配方颗粒质量保障关键技术及智能制造装备研究现状[J/OL].中药药理与临床:1-16[2021-12-28].

[19] 禹亚杰,包锐.中药配方颗粒质量控制研究现状分析与思考[J].智慧健康,2021,7(13):49-51+5413.015. 

[20] 李卫民,林江,苏毅强,李卫红.“补益剂”命名探讨[J].中医研究,2021,34(9):8-10.

[21] 王晓敏. 补益类中药的服用特点及药性分析[J].养生大世界, 2021.

[22] 郝丽莉,范越.补虚药与抗感染作用[J].中医药学报,2006,34(5):1-2.

引用本文

黄新宇, 季巧遇, 补虚类中药配方颗粒的研究进展[J]. 国际中医药研究, 2022; 2: (3) : 62-65.